Health care-associated endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.

Authors :: Chi CY
Lauderdale TL
Wang SM
Wu JM
Yang YJ
Liu CC
Source :: Journal of clinical microbiology [J Clin Microbiol] 2008 Feb; Vol. 46 (2), pp. 810-3. Date of Electronic Publication: 2007 Dec 12.
Publication Year :: 2008
Abstract: Infective endocarditis (IE) caused by methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility (SARV) has been reported worldwide. We report the successful treatment of a pediatric patient with SARV IE and characterization of the infecting strain. The MIC of vancomycin rose from 1.5 to 2 microg/ml, and the SARV was confirmed by population analysis.

Subjects :: Acetamides therapeutic use
Anti-Bacterial Agents therapeutic use
Child, Preschool
Cross Infection drug therapy
Endocarditis, Bacterial drug therapy
Female
Fusidic Acid therapeutic use
Humans
Linezolid
Methicillin Resistance
Microbial Sensitivity Tests
Oxazolidinones therapeutic use
Staphylococcal Infections drug therapy
Staphylococcus aureus isolation & purification
Cross Infection microbiology
Endocarditis, Bacterial microbiology
Staphylococcal Infections microbiology
Staphylococcus aureus drug effects
Vancomycin Resistance

Full Text Access

Tools